| Literature DB >> 25010779 |
Milan M Obradovic, Andreja Trpkovic, Vladan Bajic, Sanja Soskic, Aleksandra Jovanovic, Julijana Stanimirovic, Milos Panic, Esma R Isenovic.
Abstract
C-reactive protein (CRP) is a marker of inflammation. Atherosclerosis is now recognized as inflammatory disease, and it seems that CRP directly contributes to atherogenesis. Oxidation of low-density lipoprotein (LDL) molecule increases the uptake of lipid products by macrophages leading to cholesterol accumulation and subsequent foam cell formation. The elevated levels of high sensitivity CRP (hsCRP) and oxidized LDL (OxLDL) in the blood were found to be associated with cardiovascular diseases (CVD). In this review, we highlighted the evidence that CRP and OxLDL are involved in interrelated (patho) physiological pathways. The findings on association between hsCRP and OxLDL in the clinical setting will be also summarized.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25010779 DOI: 10.1515/cclm-2014-0590
Source DB: PubMed Journal: Clin Chem Lab Med ISSN: 1434-6621 Impact factor: 3.694